EGI
HALO icon

EAM Global Investors’s Halozyme HALO Stock Holding History

EAM Global Investors’s Portfolio HALO Stock Details HALO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-75,283
Closed -$4.31M – 141
2024
Q3 		$4.31M Buy
+75,283
New +$4.32M 0.87% 70
2023
Q1 		– Sell
-36,768
Closed -$2.09M – 132
2022
Q4 		$2.09M Buy
+36,768
New +$1.88M 0.54% 62
2022
Q3 		– Sell
-57,394
Closed -$2.52M – 201
2022
Q2 		$2.52M Buy
+57,394
New +$2.48M 0.62% 49

Other funds holding HALO

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SCM
Snyder Capital Management San Francisco, California $5.16B AUM 26.72% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

EAM Global Investors's HALO Position: Q4 2024 in Review

EAM Global Investors sold out of Halozyme (HALO) in Q4 2024, closing a stake of 75,283 shares — an estimated $4.31M sold.

EAM Global Investors first reported a position in HALO in Q2 2022 and held it in 3 quarters. The position peaked at $4.31M in Q3 2024. 508 funds tracked by Wall St. Rank hold HALO as of Q4 2024.

  • EAM Global Investors reported no remaining Halozyme position as of Q4 2024 after selling out during the quarter.
  • EAM Global Investors sold 75,283 Halozyme shares in Q4 2024, an estimated $4.31M.
  • EAM Global Investors first reported a position in Halozyme in Q2 2022 and held it in 3 quarters.
  • EAM Global Investors's Halozyme position peaked at $4.31M in Q3 2024.
  • 508 funds tracked by Wall St. Rank held Halozyme as of Q4 2024.

Based on EAM Global Investors's 13F filing for Q4 2024, filed 13 Feb 2025.